BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 24, 1999
View Archived Issues
Synsorb Biotech licenses potential cystic fibrosis therapies
Read More
MiniMed enters collaboration with Elan for Medipad drug delivery system
Read More
Copley launches first controlled drug
Read More
Company Profile: Probiodrug
Read More
Cell Pathways completes phase III APC trial analysis
Read More
Amarillo Biosciences reaches IFN-alpha development agreement in China
Read More
Two gene therapy clinical trials under way for coronary artery disease
Read More
PowderJect and Glaxo Wellcome further expand DNA vaccine alliance
Read More
FDA approves new glucose monitoring system
Read More
Solvay announces commencement of tender offer to acquire Unimed
Read More
Gliatech presents results of new antiinflammation program
Read More
Immune Response implements restructuring plan
Read More
Avant receives approval to conduct clinical trial of atherosclerosis vaccine
Read More
CLX-0901: a novel compound for the treatment of type II diabetes
Read More
Calyx scientists identify CLX-0301, a novel antidiabetic and candidate for clinical testing
Read More
Takeda presents new compounds for asthma, allergic disorders
Read More
Ion and collaborators focus efforts on sickle cell disease and proliferative disorders
Read More
Erythromycin derivatives prepared under Taisho-Sagami collaboration
Read More
AM-6898E: new anti-IgE antibody agent for immune disorders
Read More
Does melatonin improve the tolerability of chemotherapy?
Read More
Antidiabetic activity and mechanism of action of R-102380, a novel TZD from Sankyo
Read More
Early indications of antidiabetic potential for adenosine A1 agonist from Glaxo Wellcome
Read More
Potential new use for donepezil: Rx of dyskinesias and other symptoms in IPD
Read More
CRF1 receptor antagonist may be beneficial in stress-induced psychosomatic disorders
Read More
GlycoDesign expands GD0039 phase II cancer trial to additional site
Read More